TechWald Holding S.p.A.

TechWald Holding S.p.A. is an Italian private investment firm specializing in early-stage healthcare innovation, with a strategic focus on the MedTech industry and medical technologies. The firm supports high-growth potential companies committed to developing healthcare innovations, including medical devices, equipment, digital devices, and services that provide value for patients, doctors, and healthcare systems. TechWald Holding aims to deliver sound and ethical profits to its shareholders by investing in technologies that enhance patient outcomes and healthcare efficiency.

The firm's investment strategy emphasizes large and fast-growing healthcare segments such as cardiovascular, neurovascular, neuromodulation, metabolic diseases, and general surgery & endoscopy. Additionally, TechWald Holding focuses on cross-sector technological and therapeutic trends, including minimally invasive procedures, interventional versus surgical approaches, precision medicine, and patient remote monitoring. This approach enables the firm to identify and support innovative solutions that address significant medical needs and improve healthcare delivery.

TechWald Holding has a track record of co-investing in significant funding rounds, such as the €17.9 million Series B financing of Lymphatica Medtech SA, a Swiss company specializing in innovative treatments for lymphedema. This investment underscores TechWald Holding's commitment to advancing healthcare innovation and supporting companies that develop groundbreaking medical technologies. The firm's strategic partnerships and investments reflect its dedication to fostering the growth of early-stage companies that contribute to the advancement of healthcare solutions.